CLEOPATRA ENAKHENA: Open Payments
NPI 1558733998 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,591 in 138 payments from 12 companies in 2025. Trend: 2023 $1,257 · 2024 $1,883 · 2025 $2,591
Food & beverage: $2,585Education: $5
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $383 |
| Teva Pharmaceuticals USA, Inc. | 20 | $351 |
| E.R. Squibb & Sons, L.L.C. | 16 | $291 |
| Alkermes, Inc. | 13 | $275 |
| Janssen Pharmaceuticals, Inc | 10 | $272 |
| Axsome Therapeutics, Inc. | 9 | $242 |
| ABBVIE INC. | 12 | $220 |
| Otsuka America Pharmaceutical, Inc. | 16 | $172 |
| Vanda Pharmaceuticals Inc. | 9 | $172 |
| Lundbeck LLC | 9 | $158 |
Products named: INGREZZA, COBENFY, ARISTADA, INVEGA SUSTENNA, Auvelity, AUSTEDO XR, ABILIFY MAINTENA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
